With the increasingly complex and consistently evolving biopharma industry, companies are looking for consultancies that are able to provide significant regulatory leadership, product development consulting, and expertise in all stages from early-stage discovery to commercialization.
Moreover, the growing importance of new biologics drugs is seen over the last few years, with biologics contributing to 25% of new molecule approvals in the US in 2020. This further boosts the demand for biologics consulting services market.
Continue reading here: https://bit.ly/3xI76z4
#BiotechPharma #Biotech #pharmaceutical #pharma #healthcare #medicine #BostonBioPharmaConsultants